-
Expanded Access to Experimental Biologics
Expanded access, sometimes called “compassionate use,” is the use outside of a clinical trial of an investigational medical product (i.e., one that has not been approved by FDA). FDA is committed to…
-
Approved Blood Products
Products that are regulated as Biologics License Applications (BLAs), New Drug Applications (NDAS), Premarket Approvals (PMAs), and 510(k)s.
-
Other Recommendations for Biologics Manufacturers
We have recently redesigned the FDA Web site. As a result, some Web links (URLs) embedded within Guidances, Rules and other documents are no longer valid. If you find a link that does not work, please…
-
Compliance Actions (Biologics)
CBER carries out a wide range of compliance and surveillance activities during the “life cycle” of biological products
-
Industry (Biologics)
CBER’s Manufacturers Assistance and Technical Training Branch provides assistance and training to industry, including large and small manufacturers and trade associations, and to respond to requests for…
-
Pulse Oximeter Basics
A pulse oximeter, or pulse ox, is a device that estimates the amount of oxygen in the blood. Here’s what to know before using one.
-
Mindfulness and the challenge of climbingVeterans learn to combine mindfulness with the challenge of climbing.
-
FDA Roundup: March 18, 2025
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
-
Pandemics & Emerging Diseases
Pandemics & Emerging Diseases
-
GARDASIL 9
Product approval information for Human Papillomavirus 9-valent Vaccine, Recombinant also known as Gardasil 9.
- Load More